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BACKGROUND: Clinician’s knowledge of a woman’s
cancer family history (CFH) and counseling about
health-related behaviors (HRB) is necessary for appro-
priate breast cancer care.
OBJECTIVE: To evaluate whether clinicians solicit CFH
and counsel women on HRB; to assess relationship of
well visits and patient risk perception or worry with
clinician’s behavior.
DESIGN: Cross-sectional population-based telephone
survey.
PARTICIPANTS: Multiethnic sample; 1,700 women
from San Francisco Mammography Registry with a
screening mammogram in 2001–2002.
MEASUREMENTS: Predictors: well visit in prior year,
self-perception of 10-year breast cancer risk, worry
scale. Outcomes: Patient report of clinician asking
about CFH in prior year, or ever counseling about
HRB in relation to breast cancer risk. Multivariate
models included age, ethnicity, education, language of
interview, insurance/mammography facility, well visit,
ever having a breast biopsy/follow-up mammography,
Gail-Model risk, Jewish heritage, and body mass index.
RESULTS: 58% reported clinicians asked about CFH;
33% reported clinicians ever discussed HRB. In multi-
variate analysis, regardless of actual risk, perceived
risk, or level of worry, having had a well visit in prior
year was associated with increased odds (OR=2.3; 95%
CI 1.6, 3.3) that a clinician asked about CFH. Regard-
less of actual risk of breast cancer, a higher level of
worry (OR=1.9; 95% CI 1.4, 2.6) was associated with
increased odds that a clinician ever discussed HRB.
CONCLUSIONS: Clinicians are missing opportunities to
elicit family cancer histories and counsel about health-
related behaviors and breast cancer risk. Preventive
health visits offer opportunities for clinicians to address
family history, risk behaviors, and patients’ worries
about breast cancer.
KEY WORDS: family history; breast cancer; risk assessment;
multiethnic.
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BACKGROUND
Women with a family history of breast and/or ovarian cancer
are at increased risk for breast cancer. Although only 5–10% of
breast cancer cases result from known and testable genetic
mutations, women at high risk for those mutations should be
referred for genetic counseling and testing.
1 Without soliciting
an adequate family history of cancer, primary care physicians
cannot assess risk adequately and make these referrals.
1–5 For
other women with a family history, an interaction of genetics
and environment can increase their risk for breast cancer.
6
Fatty diet, high alcohol intake, low physical activity, and
obesity are all modifiable environmental/behavioral risk fac-
tors for breast cancer.
7–10
Patients’ report of their family history of breast cancer is
quite accurate.
11 Prior research in a largely White population
suggests that physicians obtain some element of a family
history during half of new patient visits and almost one-
quarter of follow-up visits.
4,12 These relatively low rates may
in part be explained by low self-efficacy in relation to genetic
disease screening among primary care physicians.
3 However,
physicians do appropriately tailor breast cancer risk reduc-
tion recommendations and refer for genetic counseling and
testing when given standardized patient scenarios.
13,14 In
contemporary busy practice settings, physician behavior may
be more influenced by limited time and the patients’ own
concerns.
15–17
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308Research has demonstrated links among family history,
disease-specific perceived risk, and disease-specific worry.
18
However, associations between the degree of cancer worry and
clinicians’ risk counseling behaviors are poorly understood,
especially among women varying in risk. Clinicians may under-
estimate the degree to which patients worry about cancer,
depending on their self-efficacy communicating about difficult
issues.
19 A cross-sectional study among women at high risk of
breastcancerfoundthatsolicitationoffamilyhistoryinageneral
medicine setting was associated with less cancer worry.
20
This study adds to the current literature by assessing rates
of family cancer history elicitation and counseling on modifi-
able behavioral risk factors for breast cancer among a
multiethnic sample of women at both high and average breast
cancer risk. It further investigates whether these activities
were related to opportunities for delivering preventive health
care and to patients’ perceived risk or worry about breast
cancer. Our hypothesis was that women who either had a well
visit in the past year or who endorsed feeling worried about
breast cancer would be more likely to report that their
clinicians had elicited their family cancer histories and had
counseled them on behavioral risk factors.
METHODS
Setting, Sample Selection, and Eligibility
This is a cross-sectional study of a telephone survey conducted
between March and July 2003 about breast cancer risk
reduction practices. Details of the survey are available else-
where, and are described briefly here.
21–24 Participants were
identified through the San Francisco Mammography Registry
(SFMR), a population-based registry in the National Cancer
Institute Breast Cancer Surveillance Consortium.
25 Patient
data were gathered from 5 participating facilities. Women were
eligible if they had a screening mammogram between 2001–
2002, had completed the SFMR demographic and health
information questionnaire, agreed to be contacted for possible
participation in breast health research studies, had no per-
sonal history of breast cancer, were age 40–75, spoke English,
Spanish or Cantonese, and self-identified as African American,
Asian-Pacific Islander (API), Latina, or White. Based on
information from the SFMR questionnaire, the sample was
stratified by race/ethnicity and level of 5-year breast cancer
risk according to the Gail Model with the goal of recruiting
equal numbers in high versus average/low risk groups. The
Gail model is a risk-prediction model for breast cancer; women
were considered high risk if their score on the model was
>1.7.
26,27 In addition, recruitment was stratified by ethnicity
with target recruitment of equal numbers of women in each
ethnic group. A total of 14,490 women were deemed eligible.
Because of relatively small numbers, we recruited all high-risk
minority women. We randomly sampled from among high-risk
White women and from each low-risk race/ethnic group;
further details of the recruitment and participation by ethnic-
ity are available elsewhere.
21
Of the 2,715 eligible women sent recruitment letters, 1,711
completed the survey, 398 refused participation, and 606 were
unreachable (incorrect contact information, unresponsive),
resulting in a response rate of 63%. Because of missing
information, the number of completed surveys included in
the analysis was 1,700.
21
Predictor Measures: Demographic, Access,
and Breast cancer Risk Factors
Demographic factors included age, any Jewish heritage (yes/
no), education (grade school/high school or vocational school/
college or higher), and language of interview (Cantonese or
Spanish/English). Age was collected as a continuous variable
and then collapsed into 3 age groups (40–49/50–64/65–74) to
reflect differences in risk and/or screening recommendations
for women in these age groups.
28 Access to medical care
Table 1. Sociodemographic and Breast Cancer Risk-Related
Factors among a Multiethnic Sample of Women Receiving
Screening Mammography, San Francisco Bay Area
2001–2002 (N=1,700)
Unweighted % (N) Weighted %
Sociodemographic characteristics
Age
40–49 29.0 (493) 33.1
50–59 58.4 (993) 57.9
60–74 12.6 (214) 9.0
Jewish heritage
Yes 10.1 (168) 11.6
Education
Grade school or middle school 3.7 (63) 3.3
Completed high school or
vocational school
18.1 (304) 16.3
College or higher 78.2 (1318) 80.3
Language of interview
Chinese or Spanish 1.3 (192) 10.5
English 88.7 (508) 89.5
Access
Insurance and mammography facility
Academic hospital insured 35.7 (607) 37.2
Community hospital insured 13.5 (230) 12.5
Public hospital insured 3.1 (53) 3.0
Staff model HMO insured 42.6 (724) 42.5
Uninsured 4.2 (71) 4.0
Insurance information
missing
0.9 (15) 0.8
At least one well-visit in past year
Yes 87.6 (1464) 86.3
Breast cancer risk factors
Self-reported history of breast biopsy or abnormal mammography
Yes 52.9 (895) 48.9
Body mass index
≤25 47.9 (798) 51.5
26–29 28.5 (476) 27.4
≥30 23.6 (393) 21.1
Risk perception and worry
Self-perception of 10-year risk of breast cancer
Higher than other same-age
women
30.1 (487) 29.0
Same or lower than other
same-age women
69.9 (1132) 71.0
Worry scale (mean, SD or SE)
(Range 1–4) 1.3,
SD=0.42
1.3,
SE=0.011
Clinician risk assessment
Clinician asked in the past year about general family cancer history
Yes 58.0 (971) 58.0
Clinician ever discussed health-related behaviors in relation to breast
cancer risk
Yes 34.4 (582) 33.1
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raphy facility because these 2 variables were highly correlated
(academic hospital insured/community hospital insured/pub-
lic hospital insured/staff model HMO insured/uninsured/
insurance information missing); and, having had a well visit
in the last year (yes/no). The well visit measure was based on a
survey question, which asked if any of the woman’s visits in
the past year with a physician or nurse practitioner was “for a
check-up, meaning a visit even when you were well?”
Breast cancer risk factors included the woman’s body mass
index calculated from self-report of height and weight using
the formula kg/m
2 (≤25/26–29 overweight/≥30 obese) and a
measure of past breast abnormality (yes/no). This last mea-
sure was assigned a “yes” if the woman answered yes to either
having had a breast biopsy in the past or having had a
mammogram result that required obtaining a follow-up mam-
mogram afterward, and a “no” if she answered no to both
questions.
Predictor Measures: Perceived Breast Cancer Risk
and Worry
Breast cancer risk and worry factors included both the
woman’s self-perception of her 10-year risk of breast cancer
(higher than other same-age women/same or lower than other
same-age women),
22 and a woman’s score on a scale of worry
about getting breast cancer (range 1–4: rare or no worry to
frequent worry). Based on Lerman’s scale, the worry scale
consisted of 3 questions about frequency of worry, thoughts
about risk of getting breast cancer, and the effect of that worry
on mood and functioning.
29,30 These 3 questions loaded on a
single worry factor. Salient factor loadings ranged from 0.55 to
0.80, and the rotated factor resulted in a simple factor
structure. Reliability for the worry scale was good (Cronbach
alpha=0.65). In keeping with standard practice in psychomet-
ric analysis, we scored this as a unidimensional scale and
analyzed it as a continuous variable.
31,32
Table 2. Association of Sociodemographic and Breast Cancer Risk-Related Factors with Report of Clinicians’ Discussion of Cancer Family
History (CFH) and Breast Cancer Health Related Behaviors (HRB) (N=1,700)
Predictor Clinician asked in the past year about CFH
(N=1,675)
Clinician ever discussed HRB
(N=1,694)
Weighted
%
Unadjusted odds ratios
95 % CI
P value Weighted
%
Unadjusted odds ratios
95 % CI
P value
Sociodemographic characteristics
Age
40–49 65.4 <.0001 27.5 .001
50–64 56.5 0.7 (0.5–.09) 37.1 1.6 (1.2–2.0)
65–74 41.4 0.4 (0.3–0.5) 28.6 1.1 (0.7–1.6)
Jewish heritage
Yes 54.9 0.9 (0.6–1.3) .46 25.8 0.7 (0.5–1.0) .05
Education
Grade school or middle school 60.8 .15 27.8 .71
Completed high school/vocational
school
63.3 1.1 (0.6–2.0) 33.3 1.3 (0.7–2.4)
College or higher 56.8 0.8 (0.5–1.5) 33.1 1.3 (0.7–2.3)
Language of interview
Chinese or Spanish 63.7 .12 28.6 .19
English 57.4 0.8 (0.5–1.1) 33.7 1.3 (0.9–1.8)
Access
Insurance and mammography Site
Academic hospital insured 55.4 0.4 (0.1–1.9) .13 36.5 1.4 (0.4–4.3) .09
Community hospital Insured 54.2 0.4 (0.1–1.9) 34.9 1.3 (0.4–4.1)
Public hospital insured 50.4 0.4 (0.1–1.7) 40.5 1.6 (0.4–5.8)
Staff model HMO insured 60.8 0.6 (0.1–2.4) 28.9 1.0 (0.3–3.0)
Uninsured 68.4 0.8 (0.2–3.6) 36.9 1.4 (0.4–4.8)
Insurance information missing 73.9 29.8
At least one well visit in past year
Yes 60.4 1.9 (1.4–2.7) .0001 33.9 1.3 (0.9–1.8) .15
Breast cancer risk factors
Self-reported history of breast biopsy
or follow-up mammography
Yes 58.5 1.0 (0.8–1.3) .75 36.1 1.3 (1.0–1.7) .003
Body mass index
≤25 58.4 .2 29.2 .003
26–29 61.1 1.1 (0.9–1.5) 33.9 1.2 (0.9–1.6)
≥30 54.0 0.8 (0.6–1.1) 40.3 1.6 (1.2–2.2)
Risk perception and worry
Self-Perception of 10-year risk of
breast cancer
Higher than other same-age
women
61.4 1.2 (0.9–1.5) .18 38.2 .02
Same or lower than other same-
age women
57.2 31.2 1.4 (1.1–1.8)
Worry scale (mean, SE)
Yes 1.32; .016 1.5 (1.1–2.0) .006 1.37; .021 2.0 (1.5–2.6) <.0001
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of Family Cancer History and Counseling
on Health-related Behaviors
Two outcome measures reflect physician–patient communica-
tion and information exchange vital to assessing breast cancer
risk. First, the woman was asked to report whether or not a
doctor or nurse had asked during the past year about her
cancer family history (CFH-yes/no). Then the woman was
asked whether a doctor or nurse had ever discussed with her
the risks or benefits of health related behaviors (HRB)—fatty
foods, alcohol, regular physical activity, or bodyweight—in
relation to breast cancer (yes/no). For the second outcome,
we created 1 variable based on the 5 questions, dichotomized
into those women who responded yes to at least 1 of the 5 HRB
questions versus those who answered no to all 5 items.
Weighting for Sampling Design
The sampling design was stratified by ethnicity and risk-level,
resulting in 8 ethnicity-risk strata: African Americans of low/
average (n=296) and high (n=30) risk; Asian-Pacific Islanders
of low/average (n=204) and high (n=152) risk; Latinas of low/
average (n=288) and high (n=42) risk; and Whites of low/
average (n=364) and high (n=324) risk. The original goal of
sampling equal numbers of women from each stratum was not
realized, primarily because of the lower prevalence of high-risk
non-White women. Sample weights for each stratum were
calculated as the number of women within the stratum on the
SFMR master list used for this study, divided by the stratum
sample size. We then rescaled the weights so that they
summed to the sample size in the pooled data. The rescaled
weights were used in all analyses.
Data Analysis
Data were analyzed using the STATA statistical package survey
design functions to account for the sampling design.
33 We
performed descriptive statistics of the entire sample. We
conducted bivariate analyses to compare women who reported
that their clinicians did and did not ask about their CFH in the
past year on demographic, access, breast cancer risk, per-
ceived risk, and worry factors. Then we compared women who
reported that their clinicians did and did not ever discuss at
least 1 HRB in relation to breast cancer. We included
demographic variables, such as language of interview and
education, in the bivariate analyses because of their potential
impact on the quality of patient–clinician communication.
Likewise, we included Jewish heritage in the bivariate analyses
because many of these women are at increased risk for breast
cancer, potentially affecting both their degree of worry and
communication with clinicians. Categorical predictors were
evaluated using χ
2 tests, and continuous predictors were
evaluated using t tests. We report weighted percentages and
weighted statistics to account for the sampling design.
In addition, we tested 2 weighted multivariate logistic
regression models, 1 for each of the 2 outcomes—assessment
of cancer family history (CFH), and health-related behavior
counseling (HRB). Both models included report of a well visit in
the last year, perception of breast cancer risk, and worry about
breast cancer as the predictors of primary interest. Age,
language of interview, Jewish heritage, education, insurance-
mammography facility, history of follow-up mammography,
and body mass index were all forced into the models as
potential confounders. We included all of the potential con-
founders in the multivariate models, regardless of their
significance level in the bivariate analyses, to assess the
impact of the predictor variables while simultaneously ac-
counting for other factors which have face validity for potential
influence on clinician–patient communication (e.g., language
and education). We did not include the sampling stratification
variables (race/ethnicity and risk level) in our models. We
found no evidence of colinearity among the variables included
in the final multivariate models.
RESULTS
Descriptive Results
In Table 1 we report unweighted percentages and counts and
weighted percentages describing sociodemographic, breast
cancer risk, and risk perception factors for the 1,700 women
in the sample. Of the women who reported they were asked
about CFH, 40% reported also having discussed HRB.
Bivariate Results
Table 2 shows bivariate associations of demographic, access,
and breast cancer risk and worry variables with participant
report that their clinicians asked in the past year about their
CFH or ever discussed HRB in relation to breast cancer risk.
We present these results as weighted percentages, as well as
unadjusted, weighted odds ratios.
Table 3. Odds that a Clinician Asked about Cancer Family History
(CFH) or Discussed Breast Health-Related Behaviors (HRB)
(N=1,700)*
Predictor Clinician asked
about CFH
Weighted OR
(95% CI)
†
Clinician ever
discussed breast
cancer HRB
Weighted OR (95% CI)
†
Age
40–49 Reference Reference
50–64 0.7 (0.5–0.9) 1.6 (1.2–2.1)
65–74 0.4 (0.3–0.6) 1.1 (0.7–1.7)
Worry about breast cancer
(continuous
1=lowest worry,
4=highest worry)
1.4 (1.0–1.9) 1.9 (1.4–2.6)
Perceived 10-year risk of breast cancer
Low/Average Reference Reference
High 1.1 (0.9–1.5) 1.3 (1.0–1.7)
Well-visit in past year
None Reference Reference
At least one 2.3 (1.6–3.3) 1.2 (0.8–1.8)
Jewish heritage
No Reference Reference
Yes 1.0 (0.6–1.4) 0.6 (0.4–0.9)
Body mass index
<25 Reference Reference
25–29 1.1 (0.8–1.4) 1.2 (0.9–1.6)
Q30 0.8 (0.6–1.1) 1.5 (1.1–2.1)
*Adjusted for education, language of interview, insurance/mammogra-
phy facility, ever having a biopsy or follow-up mammography.
†Significant results are in bold.
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Women in the 50- to 64-year-old group had lower odds than
women in their 40s of having been asked about their CFH in
the last year; whereas women aged 65–74 were least likely to
have been asked. Women aged 50–64 had 50% higher odds
than women in their 40s of having discussed HRB in relation
to breast cancer risk. Greater worry about breast cancer was
associated with almost a twofold increase in the odds of
reporting that clinicians had discussed HRBs. Although not
significant for HRB, women reporting a well visit in the past
year were 2 times as likely to report that a clinician had asked
about their CFH of cancer compared to those with no well visit
in the past year. Having an obese BMI—but not an overweight
BMI—was associated with higher odds of having discussed
HRBs and breast cancer risk. Conversely, being of Jewish
heritage was associated with significantly lower odds of having
discussed HRBs. Neither BMI nor Jewish heritage was associ-
ated with being asked about CFH. In these weighted, adjusted
models, perception of risk was not significantly associated with
either outcome (Table 3).
DISCUSSION
In this study, we evaluated the extent to which clinicians
discuss women’s family history and risk behaviors related to
cancer, and whether these clinician behaviors were related to
women having had a well visit and degree of cancer worry. We
found that even among women who have been screened for
breast cancer by mammography, clinicians appeared to be
missing opportunities to elicit and update family cancer
histories, and to counsel women about health-related beha-
viors and risk for breast cancer.
The low rates of family cancer history screening reported by
women in our study are consistent with findings by Murff et al,
which showed even lower rates (26%) of chart documentation
about family history of breast cancer.
34 Their study found that
White women were more likely to have documentation of a
family breast cancer history assessment than minorities.
Because our analyses were weighted for differential recruit-
ment by ethnicity and breast cancer risk level, we did not
include these sampling stratification variables in our models,
and thus are not able to compare effects by ethnic group;
however, we can conclude that our findings are valid across
our very heterogeneous sample of women.
In our study, clinician elicitation of CFH was associated with
women having had a well visit. This type of visit may be more
likely to trigger attention to family history both because there
are not as many competing concerns during the visit and
because there is ample time to attend to preventive health
care. Certainly, time limitations have been cited by physicians
as a barrier to discussion of cancer risk reduction with
patients.
35 Given increasing time pressures and patient acuity
in ambulatory medicine,
36,37 this finding is of concern. The
Center for Disease Control and Prevention’s Office of Genomics
and Disease Prevention has an ongoing Family History Public
Health Initiative to facilitate both public and medical commu-
nity understanding of the importance of family history to
disease risk, including breast cancer risk.
38 As the medical
community is presented with increasing opportunities for
genetic testing, decisions about undergoing this testing should
be guided by the patient’s family history, as is the case in
genetic testing for breast cancer.
39,40 Without this simple yet
vital piece of information, clinicians will be less likely to
identify families with strong genetic predispositions for breast
cancer.
We found that women reported lower rates of counseling
about HRB than CFH. This is consistent with results of a
physician survey about lifestyle counseling conducted by our
group, which found that only 56% of primary care physicians
reported counseling women about physical activity, 55% about
diet, and 45% about alcohol.
24
When HRB counseling does occur, it is associated with the
woman’s worry about breast cancer. However, prospective
studies are needed to determine whether HRB counseling
elevates a woman’s worry, or whether worry influences the
clinician’s counseling practices. If the former is true, patient
education interventions may not be very effective in reducing
cancer worry.
41 Regardless of the causal order between worry
and physicians’ risk counseling, targeted interventions to
increase clinician sensitivity to patients’ level of cancer worry
appear indicated.
19
We found that older women were less likely to report being
asked about CFH, but—for those in the 50- to 64-year old age
group—more likely to report being counseled on HRB. This
may reflect the fact that clinicians’ recommendations about
mammogram screening for women 40–49 may be more
strongly influenced by family history than for older women,
thus leading them to be more likely to ask younger women
about family history. An alternative explanation for the lower
prevalence of CFH among older women is possible misclassi-
fication of visits for which CFH is indicated as we were unable
to distinguish between initial visits and follow-up visits. It is
possible that follow-up visits for chronic conditions, which will
not require a review of CFH if one was recently done, may
occur more frequently among older women. However, even if
this relationship is attenuated, it is important for clinicians to
revisit their patients’ family history over time because even as a
patient ages, so does her family. Thus, a woman’s risk may
increase not only because of her age, but because of changes
in her family history as she ages. The clinician may not know
about this change in family history unless s/he asks over time
at follow-up visits.
In contrast, both physicians and patients may become more
conscious of physical changes such as weight gain and the
importance of exercise as women enter their 50s and 60s,
prompting a discussion of the potential health advantages of
behavioral change. It is also possible that clinicians counsel
middle-aged women about HRB in relation to multiple disease
states at once. This is consistent with our finding that obese
women were more likely to report HRB counseling in relation to
breast cancer; physicians may emphasize to these women the
dangers of obesity and the importance of exercise and weight
loss for risk reduction across a number of diseases at once,
including breast cancer. We also found that women of Jewish
heritage were less likely to have been counseled about HRB in
relation to breast cancer, possibly reflecting a bias on the part
of the physician, patient, or both that genetic factors greatly
outweigh behaviors for breast cancer risk in this group.
There are several limitations to our study. First, it was
conducted among women screened for breast cancer with
mammography. These women are already in the health care
system receiving preventive care. However, we expect these
women are more likely than unscreened women to have
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results obtained in a screened population may actually
overestimate clinician risk assessment behaviors in the gener-
al population.
Next, our information about clinician discussions was based
on patient report, possibly leading to significant recall bias.
This is perhaps most true for the influence of worry on the
women’s report of discussion about HRB; women who are
more worried about their breast cancer risk may be more likely
to recall the discussion. However, it remains striking that
worry is strongly associated with counseling across ethnic and
risk groups. Characteristics associated with inaccurate risk
perception among this group of women have been published in
detail already by our group.
22
Lastly, we were unable to separate out general family history
of cancer from family history of breast cancer as our survey
question did not specify any type of cancer. By asking a more
general question, which includes any type of cancer in the
family, our results may overestimate how many women were
asked about breast cancer history.
CONCLUSION
In conclusion, there appear to be substantial missed opportu-
nities for clinicians to elicit family cancer histories and counsel
about health-related behaviors and breast cancer risk. It may
be that more time for preventive health visits would allow
clinicians to address family history, risk behaviors, and
patients’ worries about breast cancer. Other system-based
interventions could also be developed either to facilitate
clinician breast cancer risk assessment and counseling, or to
allow for tailored health education outside of the already
overburdened clinician–patient encounter.
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